111 related articles for article (PubMed ID: 12949839)
1. Androgen-independent expression of adrenomedullin and peptidylglycine alpha-amidating monooxygenase in human prostatic carcinoma.
Jiménez N; Abasolo I; Jongsma J; Calvo A; Garayoa M; van der Kwast TH; van Steenbrugge GJ; Montuenga LM
Mol Carcinog; 2003 Sep; 38(1):14-24. PubMed ID: 12949839
[TBL] [Abstract][Full Text] [Related]
2. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
[TBL] [Abstract][Full Text] [Related]
3. Adrenomedullin (AM) and AM receptor type 2 expression is up-regulated in prostate carcinomas (PC), and AM stimulates in vitro growth of a PC-derived cell line by enhancing proliferation and decreasing apoptosis rates.
Mazzocchi G; Malendowicz LK; Ziolkowska A; Spinazzi R; Rebuffat P; Aragona F; Ferrazzi E; Parnigotto PP; Nussdorfer GG
Int J Oncol; 2004 Dec; 25(6):1781-7. PubMed ID: 15547717
[TBL] [Abstract][Full Text] [Related]
4. Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo.
Ouafik L; Sauze S; Boudouresque F; Chinot O; Delfino C; Fina F; Vuaroqueaux V; Dussert C; Palmari J; Dufour H; Grisoli F; Casellas P; Brünner N; Martin PM
Am J Pathol; 2002 Apr; 160(4):1279-92. PubMed ID: 11943713
[TBL] [Abstract][Full Text] [Related]
5. Catalytically active peptidylglycine alpha-amidating monooxygenase in the media of androgen-independent prostate cancer cell lines.
Trendel JA; Ellis N; Sarver JG; Klis WA; Dhananjeyan M; Bykowski CA; Reese MD; Erhardt PW
J Biomol Screen; 2008 Sep; 13(8):804-9. PubMed ID: 18832192
[TBL] [Abstract][Full Text] [Related]
6. Adrenomedullin and proadrenomedullin N-terminal 20 peptide in the normal prostate and in prostate carcinoma.
Calvo A; Abasolo I; Jiménez N; Wang Z; Montuenga L
Microsc Res Tech; 2002 Apr; 57(2):98-104. PubMed ID: 11921360
[TBL] [Abstract][Full Text] [Related]
7. Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells.
Berenguer C; Boudouresque F; Dussert C; Daniel L; Muracciole X; Grino M; Rossi D; Mabrouk K; Figarella-Branger D; Martin PM; Ouafik L
Oncogene; 2008 Jan; 27(4):506-18. PubMed ID: 17637748
[TBL] [Abstract][Full Text] [Related]
8. Deletion of peptide amidation enzymatic activity leads to edema and embryonic lethality in the mouse.
Czyzyk TA; Ning Y; Hsu MS; Peng B; Mains RE; Eipper BA; Pintar JE
Dev Biol; 2005 Nov; 287(2):301-13. PubMed ID: 16225857
[TBL] [Abstract][Full Text] [Related]
9. Expression and processing of peptidylglycine alpha-amidating monooxygenase messenger RNA in rat prostate.
Samos LF; Gkonos PJ
Prostate; 1996 Aug; 29(2):101-6. PubMed ID: 8700799
[TBL] [Abstract][Full Text] [Related]
10. Adrenomedullin prevents apoptosis in prostate cancer cells.
Abasolo I; Montuenga LM; Calvo A
Regul Pept; 2006 Jan; 133(1-3):115-22. PubMed ID: 16297990
[TBL] [Abstract][Full Text] [Related]
11. Peptidylglycine alpha-amidating monooxygenase- and proadrenomedullin-derived peptide-associated neuroendocrine differentiation are induced by androgen deprivation in the neoplastic prostate.
Jiménez N; Jongsma J; Calvo A; van der Kwast TH; Treston AM; Cuttitta F; Schröder FH; Montuenga LM; van Steenbrugge GJ
Int J Cancer; 2001 Oct; 94(1):28-34. PubMed ID: 11668475
[TBL] [Abstract][Full Text] [Related]
12. The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer.
Chang GT; Jhamai M; van Weerden WM; Jenster G; Brinkmann AO
Endocr Relat Cancer; 2004 Dec; 11(4):815-22. PubMed ID: 15613454
[TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin inhibits prostate cancer cell proliferation through a cAMP-independent autocrine mechanism.
Abasolo I; Wang Z; Montuenga LM; Calvo A
Biochem Biophys Res Commun; 2004 Sep; 322(3):878-86. PubMed ID: 15336545
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer.
Rocchi P; So A; Kojima S; Signaevsky M; Beraldi E; Fazli L; Hurtado-Coll A; Yamanaka K; Gleave M
Cancer Res; 2004 Sep; 64(18):6595-602. PubMed ID: 15374973
[TBL] [Abstract][Full Text] [Related]
15. Induction of peptidylglycine alpha-amidating monooxygenase in N(18)TG(2) cells: a model for studying oleamide biosynthesis.
Ritenour-Rodgers KJ; Driscoll WJ; Merkler KA; Merkler DJ; Mueller GP
Biochem Biophys Res Commun; 2000 Jan; 267(2):521-6. PubMed ID: 10631094
[TBL] [Abstract][Full Text] [Related]
16. Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts.
de Visser M; van Weerden WM; de Ridder CM; Reneman S; Melis M; Krenning EP; de Jong M
J Nucl Med; 2007 Jan; 48(1):88-93. PubMed ID: 17204703
[TBL] [Abstract][Full Text] [Related]
17. Expression and role of Foxa proteins in prostate cancer.
Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
[TBL] [Abstract][Full Text] [Related]
18. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.
Shi Y; Chatterjee SJ; Brands FH; Shi SR; Pootrakul L; Taylor CR; Datar R; Cote RJ
BJU Int; 2006 Jan; 97(1):170-8. PubMed ID: 16336351
[TBL] [Abstract][Full Text] [Related]
19. Androgens induce CD-9 in human prostate tissue.
Chuan Y; Pang ST; Bergh A; Norstedt G; Pousette A
Int J Androl; 2005 Oct; 28(5):291-6. PubMed ID: 16128989
[TBL] [Abstract][Full Text] [Related]
20. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
